financetom
Business
financetom
/
Business
/
Illumina Board Approves Grail Spin-Off; New Company to List on Nasdaq
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Illumina Board Approves Grail Spin-Off; New Company to List on Nasdaq
Jun 3, 2024 3:07 PM

05:51 PM EDT, 06/03/2024 (MT Newswires) -- Illumina ( ILMN ) said Monday that its board approved the spin-off of Grail.

The company said it expects to spin-off Grail on June 24 and the new company has applied for listing on Nasdaq under the ticker symbol "GRAL."

Illumina ( ILMN ) shareholders will retain all their stock of the company and will receive one share of Grail for every six shares of Illumina ( ILMN ) held on June 13.

Any fractional shares of Grail will be aggregated, sold in the open market, and proceeds will be distributed as cash payments to Illumina ( ILMN ) shareholders on pro rata basis, according to Illumina ( ILMN ).

Grail shares will start trading on the Nasdaq on or about June 12 on a "when issued" basis, while regular trading will begin on June 15, Illumina ( ILMN ) added.

Price: 105.43, Change: +2.06, Percent Change: +2.00

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Nurix Says Blood Cancer Therapy Bexobrutideg Gets European Orphan Drug Designation
Nurix Says Blood Cancer Therapy Bexobrutideg Gets European Orphan Drug Designation
Jul 7, 2025
08:04 AM EDT, 07/07/2025 (MT Newswires) -- Nurix Therapeutics ( NRIX ) said Monday that the European Medicines Agency has granted orphan drug designation to bexobrutideg, a treatment for Waldenstrom macroglobulinemia, or WM, a rare type of blood cancer. Bexobrutideg is currently being evaluated in a phase 1 clinical trial in patients with relapsed or refractory B-cell malignancies, including WM....
Market Chatter: BlackRock Dropped Ukraine Fund Talks Following Trump's Election as President
Market Chatter: BlackRock Dropped Ukraine Fund Talks Following Trump's Election as President
Jul 7, 2025
08:02 AM EDT, 07/07/2025 (MT Newswires) -- BlackRock ( BLK ) dropped talks with potential investors for the Ukraine Development Fund earlier this year, as US President Donald Trump took office and clashed with Ukrainian President Volodymyr Zelenskiy and Russian President Vladimir Putin, Bloomberg News reported Saturday, citing sources familiar with the matter. Bloomberg said Trump's election campaign included a...
Mercedes-Benz Q2 sales fall 9% impacted by tariffs
Mercedes-Benz Q2 sales fall 9% impacted by tariffs
Jul 7, 2025
(Reuters) -German carmaker Mercedes-Benz said on Monday its second-quarter unit sales of cars and vans fell 9%, citing the impact of tariffs. Deliveries fell to 547,100 cars and vans in the April-June period, while sales of battery electric vehicles dropped even more sharply by 18%, to 41,900 vehicles, the company said in a statement. Second-quarter sales of Mercedes' Cars unit...
Copyright 2023-2026 - www.financetom.com All Rights Reserved